International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2016 Nov 4

PMID 27806965

Citations 7

Authors

Jonathan C Hsu

Masaharu Akao

Mitsuru Abe

Karen L Anderson

Alvaro Avezum

Nathan Glusenkamp

Shun Kohsaka

Deirdre A Lane

Gregory Y H Lip

Chang-Sheng Ma

Frederick A Masoudi

Tatjana S Potpara

Teo Wee Siong

Mintu P Turakhia

Hung-Fat Tse

John S Rumsfeld

Thomas M Maddox

Affiliations

Soon will be listed here.

Citing Articles

Baseline and Postprocedural Health Status Outcomes in Contemporary Patients With Atrial Fibrillation Who Underwent Catheter Ablation: A Report from the Japanese Outpatient Registry.

Ikemura N, Spertus J, Kimura T, Katsumata Y, Fujisawa T, Ueda I J Am Heart Assoc. 2021; 10(18):e019983.

PMID: 34514817 PMC: 8649523. DOI: 10.1161/JAHA.120.019983.

Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle.

Gumprecht J, Lip G, Potpara T Int J Cardiol Heart Vasc. 2020; 26:100473.

PMID: 32142061 PMC: 7046532. DOI: 10.1016/j.ijcha.2020.100473.

Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey.

Koziel M, Simovic S, Pavlovic N, Nedeljkovic M, Paparisto V, Music L Int J Cardiol Heart Vasc. 2020; 26:100461.

PMID: 32140551 PMC: 7046541. DOI: 10.1016/j.ijcha.2019.100461.

Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile.

Gopalan B, Namboodiri N, Abdullakutty J, Lip G, Koshy A, Nair V BMJ Open. 2019; 9(7):e025901.

PMID: 31352410 PMC: 6661577. DOI: 10.1136/bmjopen-2018-025901.

Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016.

Maura G, Billionnet C, Drouin J, Weill A, Neumann A, Pariente A BMJ Open. 2019; 9(4):e026645.

PMID: 31005934 PMC: 6500377. DOI: 10.1136/bmjopen-2018-026645.

References

Rahman F, Kwan G, Benjamin E . Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014; 11(11):639-54. DOI: 10.1038/nrcardio.2014.118. View

Go A, Magid D, Wells B, Sung S, Cassidy-Bushrow A, Greenlee R . The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2009; 1(2):138-47. DOI: 10.1161/CIRCOUTCOMES.108.801654. View

Lip G, Laroche C, Dan G, Santini M, Kalarus Z, Rasmussen L . 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Am J Med. 2014; 127(6):519-29.e1. DOI: 10.1016/j.amjmed.2013.12.022. View

Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H . Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J. 2011; 75(6):1328-33. DOI: 10.1253/circj.cj-10-1119. View

Benjamin E, Wolf P, DAgostino R, Silbershatz H, Kannel W, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-52. DOI: 10.1161/01.cir.98.10.946. View

Bufalino V, Masoudi F, Stranne S, Horton K, Albert N, Beam C . The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation. 2011; 123(19):2167-79. DOI: 10.1161/CIR.0b013e3182181529. View

Dewhurst M, Adams P, Gray W, Dewhurst F, Orega G, Chaote P . Strikingly low prevalence of atrial fibrillation in elderly Tanzanians. J Am Geriatr Soc. 2012; 60(6):1135-40. DOI: 10.1111/j.1532-5415.2012.03963.x. View

Liu Y, Liu H, Dong L, Chen J, Guo J . Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People's Hospital of Peking University. Acta Cardiol. 2010; 65(2):221-4. DOI: 10.2143/AC.65.2.2047057. View

Damasceno A, Mayosi B, Sani M, Ogah O, Mondo C, Ojji D . The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med. 2012; 172(18):1386-94. DOI: 10.1001/archinternmed.2012.3310. View

10.

Kakkar A, Mueller I, Bassand J, Fitzmaurice D, Goldhaber S, Goto S . Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013; 8(5):e63479. PMC: 3660389. DOI: 10.1371/journal.pone.0063479. View

11.

Suzuki S, Yamashita T, Kato T, Fujino T, Sagara K, Sawada H . Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation. Circ J. 2007; 71(5):761-5. DOI: 10.1253/circj.71.761. View

12.

Bansal N, Fan D, Hsu C, Ordonez J, Marcus G, Go A . Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013; 127(5):569-74. PMC: 3676734. DOI: 10.1161/CIRCULATIONAHA.112.123992. View

13.

Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy T . The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98(5):476-84. DOI: 10.1016/S0002-9343(99)80348-9. View

14.

Huisman M, Lip G, Diener H, Dubner S, Halperin J, Ma C . Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. Am Heart J. 2014; 167(3):329-34. DOI: 10.1016/j.ahj.2013.12.006. View

15.

Kawabata-Yoshihara L, Scazufca M, de Souza Santos I, Whitaker A, Kawabata V, Bensenor I . Atrial fibrillation and dementia: results from the Sao Paulo ageing & health study. Arq Bras Cardiol. 2012; 99(6):1108-14. DOI: 10.1590/s0066-782x2012005000106. View

16.

Udompanich S, Lip G, Apostolakis S, Lane D . Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM. 2013; 106(9):795-802. DOI: 10.1093/qjmed/hct129. View

17.

Shen A, Yao J, Brar S, Jorgensen M, Chen W . Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007; 50(4):309-15. DOI: 10.1016/j.jacc.2007.01.098. View

18.

Kakkar A, Mueller I, Bassand J, Fitzmaurice D, Goldhaber S, Goto S . International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2011; 163(1):13-19.e1. DOI: 10.1016/j.ahj.2011.09.011. View

19.

Kohsaka S, Miyata H, Ueda I, Masoudi F, Peterson E, Maekawa Y . An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS). Am Heart J. 2015; 170(6):1077-85. DOI: 10.1016/j.ahj.2015.09.017. View

20.

Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden D, Aizawa Y . Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009; 158(4):629-36. DOI: 10.1016/j.ahj.2009.06.031. View